To assess the clinical efficacy and safety of denosumab in the prevention and treatment of osteoporosis compared to placebo or active comparator in postmenopausal women.
This is a protocol.
Denosumab for the treatment and prevention of postmenopausal osteoporosis
You may also be interested in:
- Pharmacological interventions for preventing bone density loss in critically ill people
- Bisphosphonate therapy for children and adolescents with secondary osteoporosis.
- Calcitonin for preventing and treating corticosteroid-induced osteoporosis
- Etidronate for preventing fractures caused by osteoporosis in postmenopausal women
- Intravenous zoledronate for postmenopausal osteoporosis
Health topics: